Received Jul 7, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (PFIZER-BIONTECH)) | PFIZER\BIONTECH | 1 | FH8028 | LA |
TIA; This is a spontaneous report received from a Consumer or other non HCP. A 71-year-old female patient received BNT162b2 (BNT162B2), on 11Dec2021 as dose 1, single (Lot number: FH8028) at the age of 71 years, in left arm for covid-19 immunisation. The patient's relevant medical history included: "Diabetic", start date: 2006 (ongoing), notes: diagnosed around 2006 or somewhere around there; "Hypertension" (ongoing). There were no concomitant medications. The following information was reported: TRANSIENT ISCHAEMIC ATTACK (hospitalization) with onset 11Dec2021, outcome "unknown", described as "TIA". The patient was hospitalized for transient ischaemic attack (start date: 12Dec2021, discharge date: 13Dec2021, hospitalization duration: 2 day(s)). The event "tia" required emergency room visit. Therapeutic measures were not taken as a result of transient ischaemic attack. Clinical course: The vaccine was administered in a Pharmacy/drug store and not at a military facility. The patient did not receive any other vaccines on the same date and as the Pfizer vaccine nor within 4 weeks prior to the first administration. The patient had was a TIA, confirmed to be a transient ischemic attack.
Diabetic (diagnosed around 2006 or somewhere around there); Hypertension